For Cubist's Cidecin, sales will be even smaller--only a few hundred million dollars.
FORBES: Antibiotic Breakthroughs Fall Short
Cubist's injectible antibiotic Cidecin targets S. aureus and similarly resistant bugs in hospitals.
FORBES: A Better Antibiotic?
Cubist fixed the problem and sees Cidecin as an important new medicine that could significantly boost the tiny Cambridge, Mass.
应用推荐
模块上移
模块下移
不移动